Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment

Yuki Muroyama, Thomas R. Nirschl, Christina M. Kochel, Zoila Lopez-Bujanda, Debebe Theodros, Wendy Mao, Maria A. Carrera-Haro, Ali Ghasemzadeh, Ariel E. Marciscano, Esteban Velarde, Ada J. Tam, Christopher J. Thoburn, Muniza Uddin, Alan Keith Meeker, Robert A Anders, Andrew Mark Pardoll, Charles G. Drake

Research output: Contribution to journalArticle

Abstract

Radiotherapy (RT) enhances innate and adaptive antitumor immunity; however, the effects of radiation on suppressive immune cells, such as regulatory T cells (Treg), in the tumor microenvironment (TME) are not fully elucidated. Although previous reports suggest an increased Treg infiltration after radiation, whether these Tregs are functionally suppressive remains undetermined. To test the hypothesis that RT enhances the suppressive function of Treg in the TME, we selectively irradiated implanted tumors using the small animal radiation research platform (SARRP), which models stereotactic radiotherapy in human patients. We then analyzed tumor-infiltrating lymphocytes (TIL) with flow-cytometry and functional assays. Our data showed that RT significantly increased tumor-infiltrating Tregs (TIL-Treg), which had higher expression of CTLA-4, 4-1BB, and Helios compared with Tregs in nonirradiated tumors. This observation held true across several tumor models (B16/F10, RENCA, and MC38). We found that TIL-Tregs from irradiated tumors had equal or improved suppressive capacity compared with nonirradiated tumors. Our data also indicated that after RT, Tregs proliferated more robustly than other T-cell subsets in the TME. In addition, after RT, expansion of Tregs occurred when T-cell migration was inhibited using Fingolimod, suggesting that the increased Treg frequency was likely due to preferential proliferation of intratumoral Treg after radiation. Our data also suggested that Treg expansion after irradiation was independent of TGFβ and IL33 signaling. These data demonstrate that RT increased phenotypically and functionally suppressive Tregs in the TME. Our results suggest that RT might be combined effectively with Treg-targeting agents to maximize antitumor efficacy.

Original languageEnglish (US)
Pages (from-to)992-1004
Number of pages13
JournalCancer immunology research
Volume5
Issue number11
DOIs
StatePublished - Nov 1 2017

ASJC Scopus subject areas

  • Immunology
  • Cancer Research

Fingerprint Dive into the research topics of 'Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment'. Together they form a unique fingerprint.

  • Cite this

    Muroyama, Y., Nirschl, T. R., Kochel, C. M., Lopez-Bujanda, Z., Theodros, D., Mao, W., Carrera-Haro, M. A., Ghasemzadeh, A., Marciscano, A. E., Velarde, E., Tam, A. J., Thoburn, C. J., Uddin, M., Meeker, A. K., Anders, R. A., Pardoll, A. M., & Drake, C. G. (2017). Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment. Cancer immunology research, 5(11), 992-1004. https://doi.org/10.1158/2326-6066.CIR-17-0040